|Model Endpoint||Sex Interaction|
|Estimated Effect, Women||Estimated Effect, Men||p Value|
|Change in peakVO2 at 3 months||Least-squares mean differences (95% CI):|
|0.73 (0.27–1.19)||0.50 (0.22–0.79)||0.42|
Covariates for 3-month change in peak VO2 are baseline peak VO2, days from baseline to 3-month visit, age, sex, race, BMI (≥30 kg/m2), ischemic cause, BUN, ventricular conduction prior to CPX, income, education, insulin use, adjusted heart rate (beats/min) at the end of WL 2 on CPX test, exercise duration on CPX test (<18 min), heart rate reserve on CPX test, peak respiratory exchange ratio on CPX test (<1), number of HF hospital stays in 6 months before baseline, and treatment.
Abbreviations as in Table 1.